SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vivo Bio Tech - Quaterly Results

02 Feb 2022 Evaluate
The company witnessed a 8.80% growth in the revenue at Rs. 129.20 millions for the quarter ended December 2021 as compared to Rs. 118.75 millions during the year-ago period.Net Profit of the company move down -39.12% to Rs. 13.71  millions from Rs. 22.52 millions  in the same quarter last year.Operating profit for the quarter ended December 2021 rose to 57.54 millions as compared to 47.84 millions of corresponding quarter ended December 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 129.20 118.75 8.80 360.85 356.94 1.10 517.75 553.52 -6.46
Other Income 0.00 0.00 0.00 2.44 0.00 0.00 0.79 0.53 49.06
PBIDT 57.54 47.84 20.28 144.52 136.57 5.82 177.43 125.24 41.67
Interest 12.04 5.43 121.73 31.28 22.77 37.37 35.29 30.98 13.91
PBDT 45.50 42.41 7.29 113.24 113.80 -0.49 142.14 94.26 50.80
Depreciation 17.10 13.15 30.04 52.36 38.38 36.43 55.91 51.72 8.10
PBT 28.40 29.26 -2.94 60.88 75.42 -19.28 86.23 42.54 102.70
TAX 14.69 6.74 117.95 32.09 21.58 48.70 29.37 -1.89 -1653.97
Deferred Tax 10.31 -3.64 -383.24 19.63 1.97 896.45 15.79 -13.11 -220.44
PAT 13.71 22.52 -39.12 28.79 53.84 -46.53 56.86 44.43 27.98
Equity 142.05 128.88 10.22 142.05 128.88 10.22 134.19 128.88 4.12
PBIDTM(%) 44.54 40.29 10.55 40.05 38.26 4.67 34.27 22.63 51.46

Vivo Bio Tech Share Price

28.40 -0.90 (-3.07%)
20-Apr-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1226.10
Cipla 1228.55
Zydus Lifesciences 935.00
Lupin 2326.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×